Compare DAIO & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAIO | NEPH |
|---|---|---|
| Founded | 1969 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 40.1M |
| IPO Year | 1995 | 2004 |
| Metric | DAIO | NEPH |
|---|---|---|
| Price | $3.91 | $3.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $5.22 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 64.5K | 8.6K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1000.00 |
| EPS | N/A | ★ 0.01 |
| Revenue | ★ $21,500,000.00 | $18,789,000.00 |
| Revenue This Year | $4.51 | $11.24 |
| Revenue Next Year | $30.29 | $11.58 |
| P/E Ratio | ★ N/A | $337.00 |
| Revenue Growth | N/A | ★ 32.67 |
| 52 Week Low | $2.16 | $2.66 |
| 52 Week High | $4.49 | $6.42 |
| Indicator | DAIO | NEPH |
|---|---|---|
| Relative Strength Index (RSI) | 56.16 | 53.63 |
| Support Level | $2.98 | $2.77 |
| Resistance Level | $4.10 | $3.79 |
| Average True Range (ATR) | 0.21 | 0.21 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 52.94 | 60.00 |
Data I/O Corp provides semiconductor programming, security provisioning, and intellectual property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices and secure microcontrollers. It operates as a single segment entity, with the sole objective to design, manufacture, and sell programming solutions and Programming-as-a-Service (PaaS) to the world's various electronics manufacturers including OEMs, CMs and EMS companies. The company operate in three separate locations Redmond, Washington; Shanghai, China; and Munich, Germany.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.